The Ghana AIDS Commission has unveiled plans to introduce an HIV preventive drug in 2026, aiming to reduce the spread of the virus, which saw over 15,000 new cases last year. Speaking on Tuesday, September 30, Director-General Dr. Prosper Akanbong emphasised that the initiative will not only enhance the country’s HIV prevention strategy but also foster domestic pharmaceutical production.
“We have already integrated the vaccine as a key element of our national HIV prevention programme. While initial supplies will be sourced internationally, the pharmacy organisations present today are well-positioned to begin local manufacturing,” Dr. Akanbong stated.
He added that discussions have already been held with pharmaceutical companies, with support from GIZ, to ensure a sustainable rollout. “Together with GIZ, we are on track, and in the latter part of 2026 or the early part of 2027, we should be able to produce vaccines for Ghana,” he said.
Source: Sammi Wiafe
